edaravone 21 MG/ML Oral Suspension [Radicava]
RxNorm concept 2602122, branded drug (sbd). Prescribable name: Radicava ORS 21 MG/mL Oral Suspension.
- RxCUI
- 2602122
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2602122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Radicava ORS 1050 MG per 50 ML Oral Suspension; Radicava ORS 21 MG/ML Oral Suspension; Radicava ORS 735 MG per 35 ML Oral Suspension
Related concepts
- edaravone 21 MG/ML (SCDC, consists of)
- edaravone 21 MG/ML [Radicava] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Radicava (BN, has ingredient)
- edaravone 21 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 70510232101
- 70510232102
- 70510232201
- 70510232301
- 70510232401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2602122 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2602122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2602122. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.